Open AccessSimplification to abacavir/lamivudine + atazanavir maintains viral suppression and improves bone and renal biomarkers in ASSURE, a randomized, open label, non-inferiority trial
Author(s) -
L. Bhatti,
C.B. Small,
D.A. Margolis,
H.H. Zhao,
W.G. Weinberg,
H. Edelstein,
L.L. Ross,
E. DeJesus,
M.S. Shaefer,
D.A. Wohl
Publication year - 2020
Publication title -
unc libraries
Language(s) - English
DOI - 10.17615/1n60-2634
Subject(s) - atazanavir , abacavir , lamivudine , medicine , tenofovir , virology , pharmacology , human immunodeficiency virus (hiv) , viral load , antiretroviral therapy , virus , hepatitis b virus
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom